Jade Biosciences (JBIO) Retained Earnings (2020 - 2026)
Jade Biosciences (JBIO) posted Retained Earnings of $511.6 million for Q1 2026, up 0.94% on a QoQ basis from $506.8 million in Q4 2025, and up 317.16% year-over-year from $122.6 million in Q1 2025.
Jade Biosciences (JBIO) Retained Earnings (2020 - 2026) Analysis & Trends
Jade Biosciences' Retained Earnings history runs 7 years deep, the most recent figure standing at $511.6 million for Q1 2026.
- Quarterly Retained Earnings rose 317.16% year-over-year to $511.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $511.6 million (up 317.16% YoY) and the FY2025 annual result came in at $506.8 million, up 1178.72% from the prior year.
- Retained Earnings was $511.6 million for Q1 2026 at Jade Biosciences, up from $506.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $511.6 million in Q1 2026 and bottomed at -$235.6 million in Q1 2025.
- A 5-year average of $80.7 million and a median of -$83000.0 in 2024 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 384265.06% in 2025, while the deepest fall reached 713748.48% in 2025.
- Jade Biosciences' Retained Earnings stood at -$466000.0 in 2022, then surged by 58606.44% to $272.6 million in 2023, then sank by 117.23% to -$47.0 million in 2024, then jumped by 1178.72% to $506.8 million in 2025, then gained by 0.94% to $511.6 million in 2026.
- Business Quant data shows JBIO's Retained Earnings at $511.6 million in Q1 2026, $506.8 million in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 511.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 511.55 Mn |
| Dec 31, 2025 | 506.77 Mn |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 318.86 Mn |
| Mar 31, 2025 | -235.57 Mn |
| Dec 31, 2024 | -46.98 Mn |
| Sep 30, 2024 | -227.62 Mn |
| Jun 30, 2024 | -83,000.00 |
| Mar 31, 2024 | -33,000.00 |
| Dec 31, 2023 | 272.64 Mn |
| Sep 30, 2023 | -143.01 Mn |
| Jun 30, 2023 | 265.59 Mn |
| Mar 31, 2023 | -201,000.00 |
| Dec 31, 2022 | -466,000.00 |
| Sep 30, 2022 | -771,000.00 |
| Jun 30, 2022 | -59.29 Mn |
| Mar 31, 2022 | 209.89 Mn |
| Dec 31, 2021 | -36.39 Mn |
| Sep 30, 2021 | -28.17 Mn |
| Jun 30, 2021 | -21.99 Mn |